MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, FLGT made $84,069K in revenue. -$6,608K in net income. Net profit margin of -7.86%.

Income Overview

Revenue
$84,069K
Net Income
-$6,608K
Net Profit Margin
-7.86%
Unit: Thousand (K) dollars
Revenue Breakdown
    • Clinical Institutional Contracts
    • Clinical Insurance Contracts
    • Clinical Patient Contracts
Revenue Breakdown
    • Laboratory Services
    • Therapeutic Development
Revenue Breakdown
    • Precision Diagnostics
    • Anatomic Pathology
    • Biopharma Services
    • Revenue From Contract With Custo...
Revenue Breakdown
    • US
    • Other Countries
    • CN

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenue
84,069 81,803 73,463 70,576
Cost of revenue
48,557 47,368 45,117 43,761
Gross profit
35,512 34,435 28,346 26,815
Research and development
13,860 13,480 12,395 12,344
Selling and marketing
11,642 12,286 8,465 9,041
General and administrative
23,335 26,392 25,291 22,385
Amortization of intangible assets
2,025 1,990 1,990 1,991
Total operating expenses
50,862 54,148 48,141 45,761
Operating loss
-15,350 -19,713 -19,795 -18,946
Impairment of available-for-sale debt securities
---0
Interest income
7,874 8,091 8,018 7,738
Interest expense
28 17 14 -61
Impairment loss
-9,926 --
Other (expense) income, net
-5 46 68 6
Total other income (expense), net
7,841 -1,806 8,072 7,805
Loss before income taxes
-7,509 -21,519 -11,723 -11,141
Benefit from income taxes
-683 -2,263 176 -1,433
Net loss from consolidated operations
-6,826 -19,256 -11,899 -9,709
Net loss attributable to noncontrolling interests
-218 -299 -369 -355
Net loss attributable to fulgent
-6,608 -18,957 -11,530 -9,353
Weighted average number of shares outstanding, basic, total
30,749,000 30,544,000 30,832,000 -60,333.333
Weighted average number of shares outstanding, diluted, total
30,749,000 30,544,000 30,832,000 -60,333.333
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to fulgent-$6,608K Net lossattributable to...-$218K Net loss fromconsolidated operations-$6,826K Benefit from incometaxes-$683K Interest income$7,874K Clinical PatientContracts$2,443K Clinical InsuranceContracts$32,679K Clinical InstitutionalContracts$48,947K Loss before incometaxes-$7,509K Total other income(expense), net$7,841K Revenue$84,069K Other (expense)income, net-$5K Interest expense$28K Operating loss-$15,350K Gross profit$35,512K Cost of revenue$48,557K Total operatingexpenses$50,862K Amortization of intangibleassets$2,025K General andadministrative$23,335K Selling and marketing$11,642K Research and development$13,860K

Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics, Inc. (FLGT)